Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Senate Dems Argue That Device Safety Act Will Not Curb Innovation

This article was originally published in The Gray Sheet

Executive Summary

Senate Democrats are challenging the notion that removing federal pre-emption protection for PMA-approved devices, solidified last year by the Supreme Court, will stifle innovation
Advertisement

Related Content

Big Protections For Product Makers In Medical Liability Reform Passed By House Panel
Big Protections For Device Makers In Medical Liability Reform Passed By House Panel
Dr. Maisel Goes To Washington: CDRH Advisor, Critic Joins Senior Staff
Another Fidelis dismissal
Harkin At HELP's Helm: Industry Sees Senator's Prevention Focus As Positive
Presidential Memo Reinforces Unfavorable Outlook For PMA Pre-emption
Device Industry Groups Lobby Against Bill That Would End PMA Pre-emption
Device Industry Groups Lobby Against Bill That Would End PMA Pre-emption
Thirteen Deaths Now Blamed On Medtronic’s Recalled Fidelis ICD Leads
Judge Wields Pre-emption To Dismiss Medtronic Fidelis Claims

Topics

Advertisement
UsernamePublicRestriction

Register

MT027775

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel